PharmaDrug Inc unveils plans for first-in-human clinical study with its lead drug candidate PD-001 in esophageal cancer
PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) revealed that it intends to pursue a first-in-human study of its lead drug candidate cepharanthine-2HCL (PD-001) for...